Pacira | PCRX - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Astellas Pharma JPY 1.94T 113.64B 2026-06
Bristol-Myers Squibb USD 22.32B 2.25B 2026-06
Cara Therapeutics USD 14.5M 6.44M 2026-03
Coherus Biosciences USD 60.84M 17.78M 2026-06
Heron Therapeutics USD 9.14M 4.15M 2026-03
Ironwood Pharmaceuticals USD -217.14M 44.69M 2026-03
J&J USD 84.97B 3.78B 2026-06
Ligand Pharmaceuticals USD 967.52M 29.81M 2026-06
Nektar Therapeutics USD 576.22M 486.38M 2026-03
Novo Nordisk DKK 221.28B 18.21B 2026-06
Omeros USD -228.68M 15.13M 2025-06
Pacira USD 671.98M 18.08M 2026-06
Perrigo USD 2.52B 17M 2026-06
Pfizer USD 85.19B 4.91B 2026-06
Supernus Pharmaceuticals USD 1.03B 45.58M 2026-06
Teva Pharmaceutical Industries USD 7.75B 475M 2026-06
Xeris Pharmaceuticals USD -9.73M 22.74M 2026-06
Zoetis USD 3.15B 85M 2026-06